Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Routes of Drug Administration: Enteral01:18

Routes of Drug Administration: Enteral

Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrapartum sonographic evaluation of fetal head descent in relation to maternal position: comparison between dorsal lithotomy and kneeling squat positions.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

Efficacy and tolerability of house dust mites subcutaneous immunotherapy with monomeric allergoid: an Italian multicenter study.

European annals of allergy and clinical immunology·2024
Same author

Correlation between bituberous diameter and mode of delivery in a cohort of low-risk nulliparous women.

European journal of obstetrics, gynecology, and reproductive biology·2023
Same author

LTP allergy/sensitization in a pediatric population.

Allergologia et immunopathologia·2020
Same author

Allergen Immunotherapy in the Era of SARS-CoV-2.

Journal of investigational allergology & clinical immunology·2020
Same author

Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.

European annals of allergy and clinical immunology·2020
Same journal

Glycolysis and neutrophil extracellular traps in atherosclerosis: Mechanisms, association, and therapeutic strategies.

International journal of immunopathology and pharmacology·2026
Same journal

Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV.

International journal of immunopathology and pharmacology·2026
Same journal

Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy.

International journal of immunopathology and pharmacology·2026
Same journal

Apoptosis enhancement in MCF-7 cells: Synergistic effects of doxorubicin and the novel sulfonamide Zm-093.

International journal of immunopathology and pharmacology·2026
Same journal

Primary epithelioid angiosarcoma of thyroid: A case report and review of literature.

International journal of immunopathology and pharmacology·2026
Same journal

Retraction: Adipose stem cells' antagonism in glycosylation of D-galactose-induced skin aging of nude mice and its skin recovery function.

International journal of immunopathology and pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Sublingual immunotherapy: administration, dosages, use.

F Frati1, S La Grutta, R Bernardini

  • 1Institute of Pediatrics, Department of Medical and Surgical specialty and Public Heath, Perugia, Italy. frati.f@stallergenes.it

International Journal of Immunopathology and Pharmacology
|December 1, 2009
PubMed
Summary
This summary is machine-generated.

Sublingual immunotherapy (SLIT) offers flexible administration, including novel no-updosing regimens. These approaches are as safe and effective as traditional methods, improving patient convenience.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Related Experiment Videos

Last Updated: Jun 18, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Area of Science:

  • Allergy and Immunology
  • Pharmaceutical Sciences

Background:

  • Sublingual immunotherapy (SLIT) utilizes allergen extracts in various pharmaceutical forms like solutions and tablets.
  • Current SLIT products exhibit variability in administration schedules and allergen content, despite biological or immunological standardization.

Purpose of the Study:

  • To review the current landscape of allergen extracts for sublingual immunotherapy (SLIT).
  • To evaluate the safety and efficacy of different SLIT administration schedules, including novel approaches.

Main Methods:

  • Analysis of existing pharmaceutical forms and administration schedules for SLIT products.
  • Review of clinical trial data comparing traditional updosing with no-updosing regimens in SLIT.

Main Results:

  • SLIT is available in solutions and slow-dissolving tablets, with European usage favoring single allergens.
  • Traditional SLIT involves a 4-6 week build-up phase, but rush and ultra-rush inductions are emerging.
  • No-updosing regimens demonstrate comparable safety and efficacy to traditional updosing, enhancing patient convenience.

Conclusions:

  • No-updosing SLIT regimens offer a patient-friendly alternative with favorable safety and efficacy.
  • Recommended SLIT duration ranges from 3 to 4 years, adjusted for individual clinical response.